Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
C-X-C motif chemokine ligand 5 | 0.519 | 0.769 | 5.0E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2001 | 2019 | ||||||||
|
C-X-C motif chemokine receptor 2 | 0.445 | 0.923 | 1.4E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
carbamoyl-phosphate synthase 1 | 0.590 | 0.615 | 1.1E-09 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 2007 | 2016 | ||||||||
|
caspase 1 | 0.413 | 0.885 | 3.5E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2013 | 2019 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2020 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
CD14 molecule | 0.392 | 0.885 | 4.9E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2017 | ||||||||
|
CD163 molecule | 0.427 | 0.846 | 8.3E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
centralopathic epilepsy | 0.626 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
choline dehydrogenase | 0.529 | 0.769 | 1.7E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cholinergic receptor muscarinic 3 | 0.464 | 0.885 | 0.99 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | ||||||||
|
chromosome 17 open reading frame 97 | 0.548 | 0.577 | 4.8E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
claudin 2 | 0.575 | 0.692 | 0.70 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 | ||||||||
|
claudin 3 | 0.558 | 0.615 | 0.52 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
claudin 4 | 0.514 | 0.692 | 7.0E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2018 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
corticotropin releasing hormone receptor 2 | 0.584 | 0.731 | 8.5E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
CYCS pseudogene 25 | 0.780 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2019 | |||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
defensin alpha 5 | 0.695 | 0.423 | 5.2E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 |